These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Ursodeoxycholic acid therapy in cystic fibrosis liver disease--a retrospective long-term follow-up case-control study. Kappler M, Espach C, Schweiger-Kabesch A, Lang T, Hartl D, Hector A, Glasmacher C, Griese M. Aliment Pharmacol Ther; 2012 Aug; 36(3):266-73. PubMed ID: 22670841 [Abstract] [Full Text] [Related]
11. Liver failure unmasks celiac disease in a child. Al-Hussaini A, Basheer A, Czaja AJ. Ann Hepatol; 2013 Aug; 12(3):501-5. PubMed ID: 23619270 [Abstract] [Full Text] [Related]
12. Novel developments in IBD-related sclerosing cholangitis. Ponsioen CY. Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S15-8. PubMed ID: 21640925 [Abstract] [Full Text] [Related]
13. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. Rojas-Feria M, Castro M, Suárez E, Ampuero J, Romero-Gómez M. World J Gastroenterol; 2013 Nov 14; 19(42):7327-40. PubMed ID: 24259964 [Abstract] [Full Text] [Related]
14. Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease. Siano M, De Gregorio F, Boggia B, Sepe A, Ferri P, Buonpensiero P, Di Pasqua A, Raia V. Dig Liver Dis; 2010 Jun 14; 42(6):428-31. PubMed ID: 20034860 [Abstract] [Full Text] [Related]
15. Hepatic Manifestations of Cystic Fibrosis. Sakiani S, Kleiner DE, Heller T, Koh C. Clin Liver Dis; 2019 May 14; 23(2):263-277. PubMed ID: 30947876 [Abstract] [Full Text] [Related]
16. [Cholestatic liver diseases: diagnosis and therapy of primary sclerosing cholangitis]. Opitz OG, Thimme R, Kreisel W. Dtsch Med Wochenschr; 2002 Sep 06; 127(36):1827-30. PubMed ID: 12215927 [No Abstract] [Full Text] [Related]